SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-067655
Filing Date
2017-12-29
Accepted
2017-12-29 17:07:32
Documents
2
Period of Report
2017-12-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2163
2 POA DOCUMENT poa.txt EX-24.3_758904 3522
  Complete submission text file 0001209191-17-067655.txt   7381
Mailing Address 2000 CROW CANYON PLACE SUITE 380 SAN RAMON CA 94583
Business Address 2000 CROW CANYON PLACE SUITE 380 SAN RAMON CA 94583 855 855 GALE
SELLAS Life Sciences Group, Inc. (Issuer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ARYX THERAPEUTICS,INC. 6300 DUMBARTON CIRCLE FREMONT CA 94555
Business Address
Varian John (Reporting) CIK: 0001416176 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33958 | Film No.: 171282622